Detailed information for compound 1763588

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 203.283 | Formula: C12H17N3
  • H donors: 1 H acceptors: 1 LogP: 3.01 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCNc1nc2c(n1C)cccc2
  • InChi: 1S/C12H17N3/c1-3-4-9-13-12-14-10-7-5-6-8-11(10)15(12)2/h5-8H,3-4,9H2,1-2H3,(H,13,14)
  • InChiKey: FYOLAFLVTAEHOJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis mitogen activated protein kinase 14 0.0422 0.0374 0.0374
Brugia malayi MAP kinase sur-1 0.3493 0.619 0.6424
Schistosoma mansoni serine/threonine protein kinase 0.5504 1 1
Echinococcus granulosus mitogen activated protein kinase 3 0.3493 0.619 0.619
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase 0.0422 0.0374 0.0376
Trichomonas vaginalis CMGC family protein kinase 0.3493 0.619 0.5
Echinococcus multilocularis mitogen activated protein kinase 3 0.3493 0.619 0.619
Trypanosoma brucei protein kinase, putative 0.3493 0.619 1
Echinococcus multilocularis mitogen activated protein kinase 0.3493 0.619 0.619
Echinococcus multilocularis mitogen activated protein kinase 11 0.0422 0.0374 0.0374
Echinococcus multilocularis mitogen activated protein kinase 14 0.0422 0.0374 0.0374
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.3493 0.619 0.6222
Echinococcus granulosus mitogen activated protein kinase 11 0.0422 0.0374 0.0374
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.3493 0.619 1
Echinococcus granulosus mitogen activated protein kinase 14 0.0422 0.0374 0.0374
Loa Loa (eye worm) raf kinase 0.5477 0.9949 1
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.3493 0.619 0.5
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.3493 0.619 1
Echinococcus multilocularis mitogen activated protein kinase 11 0.0422 0.0374 0.0374
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.3493 0.619 1
Trichomonas vaginalis CMGC family protein kinase 0.3493 0.619 0.5
Trichomonas vaginalis CMGC family protein kinase 0.3493 0.619 0.5
Echinococcus multilocularis raf serine:threonine protein kinase 0.5504 1 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.3493 0.619 1
Trichomonas vaginalis CMGC family protein kinase 0.3493 0.619 0.5
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.3493 0.619 1
Brugia malayi P38 map kinase family protein 2 0.0422 0.0374 0.0388
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.3493 0.619 1
Schistosoma mansoni serine/threonine protein kinase 0.3493 0.619 0.619
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.3493 0.619 1
Brugia malayi Raf kinase 0.5312 0.9636 1
Echinococcus granulosus mitogen activated protein kinase 0.3493 0.619 0.619
Giardia lamblia Kinase, CMGC MAPK 0.3493 0.619 0.5
Loa Loa (eye worm) TKL/RAF/RAF protein kinase 0.312 0.5485 0.5513

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) > 100 uM Inhibition of human BuChE using butyrylthiocholine iodide as substrate incubated for 20 mins prior to substrate addition measured for 1 hr by Ellman's method ChEMBL. 23719283
IC50 (binding) > 100 uM Inhibition of human AchE using acetylthiocholine iodide as substrate incubated for 20 mins prior to substrate addition measured for 1 hr by Ellman's method ChEMBL. 23719283

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.